Schering-Plough Corp. and its licensor, Cancer Research
Technologies, Limited, continues to pursue a patent infringement
action against companies seeking approval of a generic version of
certain strengths of TEMODAR capsules.
provides in-depth news coverage of intellectual property lawsuits involving public companies with assets of USD $1 billion or more. Coverage focuses on the infringement of intellectual property rights (including patents, copyrights, trademarks, trade dress, trade secrets, and royalties) and corporate indemnification of intellectual property violations.